Hrachya Grigoryan
Family · Mission Hills, CANPI 1093537789
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 94.1% of the total across 124 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 124 payments — averaging $26.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$564
- Gilead$251
- Genentech USA, Inc.$206
- AstraZeneca$185
- E.r. Squibb & Sons, L.L.C.$177
- Merck$168
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,05494%
- Education$1916%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 21 | $564 |
| Gilead | 4 | $251 |
| Genentech USA, Inc. | 7 | $206 |
| AstraZeneca(2 entities) | 8 | $185 |
| E.r. Squibb & Sons, L.L.C. | 10 | $177 |
| Merck | 6 | $168 |
| Incyte Corporation | 7 | $156 |
| Novartis | 8 | $143 |
| Sanofi | 4 | $124 |
| Pfizer | 5 | $124 |
| Eisai Inc. | 4 | $95 |
| Genmab U.S., Inc. | 3 | $92 |
| Bristol Myers Squibb | 3 | $87 |
| Bayer | 4 | $82 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $53 |
| Puma Biotechnology, Inc. | 2 | $52 |
| Daiichi Sankyo Inc. | 2 | $49 |
| Boehringer Ingelheim | 2 | $48 |
| Servier Pharmaceuticals LLC | 2 | $47 |
| Taiho Oncology, Inc. | 2 | $47 |
| Spectrum Pharmaceuticals Inc. | 1 | $44 |
| Coherus Oncology, Inc. | 2 | $44 |
| Agios Pharmaceuticals, Inc. | 1 | $33 |
| Exelixis Inc. | 1 | $32 |
| Astellas Pharma US Inc | 1 | $32 |
| Karyopharm Therapeutics Inc. | 1 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Legend Biotech USA Inc. | 1 | $29 |
| EMD Serono, Inc. | 1 | $29 |
| Kyowa Kirin, Inc. | 1 | $29 |
| Syndax Pharmaceuticals, Inc. | 1 | $28 |
| Tersera Therapeutics LLC | 1 | $27 |
| Sobi, Inc | 1 | $27 |
| Array Biopharma Inc | 1 | $22 |
| GSK | 1 | $20 |
| Azurity Pharmaceuticals, Inc. | 1 | $20 |
| Blueprint Medicines Corporation | 1 | $19 |
How this compares
$3,245 in reported general payments places this provider in the 90th percentile of 10,634 family providers in California.
Other family in Mission Hills
- Lori RobertsonChino Hills$475K
- Annette ShonLos Angeles$406K
- Lisa HigginsHanford$311K
- Jennifer TougasBakersfield$302K
- Kim SchaferSacramento$288K
- Dawn MeyerSan Diego$270K
- Jennifer KangCerritos$255K
- Erin DwyerSan Diego$189K
- Phyllis CasonLos Angeles$187K
- Gabriel SchwartzSan Francisco$166K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.